GL1X · GenesisL1 explorer

Research workbench

Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2- (HYDROXYMETHYL)BENZYL)-6-(1,2,3,6-tetrahydropyridin-4-yl)-3,4- dihydroquinoxalin-1(2H)-YL)ETHANONE

Analyse Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FFG
Type
protein
Length
113 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 2
UniProt
P25440
Ligands
D7B
Pockets
1 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 69% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 2protein11369% helix, 0% strandP25440

Ligands and binding sites

  • D7B · (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1, 2,3,6-tetrahydropyridin-4-yl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · 2 copies · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.470.7921D7B

Compared structures

  • 6FFG · Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6… · the same entry in another collection · chain A against A, TM-score 1.00
  • P25440 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 2 (P25440) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.